Sign in to continue:

Friday, February 13th, 2026
Stock Profile: 5G3
5G3 Logo

TalkMed Group Limited (5G3)


📊 Statistics




💰 Dividend History


No dividend history available.



📅 SGX Earnings Announcements for 5G3


Date of Broadcast Title Financial Year Ended
2025-02-25 20:06 Full Yearly Results 2024/12/31
2024-07-15 20:18 Half Yearly Results 2024/06/30
2024-02-20 20:38 Full Yearly Results 2023/12/31
2023-08-07 20:12 Half Yearly Results 2023/06/30
2023-02-22 21:48 Full Yearly Results 2022/12/31
2022-08-02 20:22 Half Yearly Results 2022/06/30
2022-02-15 20:57 Full Yearly Results 2021/12/31


TalkMed Group Limited (5G3)

Market: SGX | Currency: SGD

Address: 3 Mount Elizabeth

TalkMed Group Limited, an investment holding company, provides medical oncology, stem cell transplants, palliative care, and other related services in Singapore, China, Hong Kong, Vietnam, India, New Zealand, Australia, and the United States. It operates through two segments: Oncology Services; and Cellular and Gene Therapy Related Products and Services. The company offers medical oncology services in the areas of breast, colon, lung, liver, biliary and pancreatic, gastro-intestinal, head and neck, genitourinary and gynaecological, and haematology malignancies and brain cancers, as well as lymphoma and leukaemia. It also provides palliative care services comprising cancer pain management, discharge and home care planning, Show more



📈 TalkMed Group Limited Historical Chart




🧾 Recent Financial Statement Analysis




📰 Related News & Research


Showing results matched by any of: 5G3, TalkMed Group Limited, TalkMed, TKMED SP, TALKMED GROUP LTD, TALKMED GROUP